Your browser doesn't support javascript.
loading
A Human Lung Challenge Model to Evaluate the Safety and Immunogenicity of PPD and Live Bacillus Calmette-Guérin.
Davids, Malika; Pooran, Anil; Hermann, Clemens; Mottay, Lynelle; Thompson, Fawziyah; Cardenas, Jacob; Gu, Jinghua; Koeuth, Thearith; Meldau, Richard; Limberis, Jason; Gina, Phindile; Srivastava, Shashikant; Calder, Bridget; Esmail, Aliasgar; Tomasicchio, Michele; Blackburn, Jonathan; Gumbo, Tawanda; Dheda, Keertan.
Afiliação
  • Davids M; Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.
  • Pooran A; South African Medical Research Council/University of Cape Town Centre for the Study of Antimicrobial Resistance, Cape Town, South Africa.
  • Hermann C; Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.
  • Mottay L; South African Medical Research Council/University of Cape Town Centre for the Study of Antimicrobial Resistance, Cape Town, South Africa.
  • Thompson F; Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Cardenas J; Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.
  • Gu J; South African Medical Research Council/University of Cape Town Centre for the Study of Antimicrobial Resistance, Cape Town, South Africa.
  • Koeuth T; Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.
  • Meldau R; South African Medical Research Council/University of Cape Town Centre for the Study of Antimicrobial Resistance, Cape Town, South Africa.
  • Limberis J; Baylor Institute for Immunology Research, Dallas, Texas; and.
  • Gina P; Baylor Institute for Immunology Research, Dallas, Texas; and.
  • Srivastava S; Baylor Institute for Immunology Research, Dallas, Texas; and.
  • Calder B; Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.
  • Esmail A; South African Medical Research Council/University of Cape Town Centre for the Study of Antimicrobial Resistance, Cape Town, South Africa.
  • Tomasicchio M; Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.
  • Blackburn J; South African Medical Research Council/University of Cape Town Centre for the Study of Antimicrobial Resistance, Cape Town, South Africa.
  • Gumbo T; Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.
  • Dheda K; South African Medical Research Council/University of Cape Town Centre for the Study of Antimicrobial Resistance, Cape Town, South Africa.
Am J Respir Crit Care Med ; 201(10): 1277-1291, 2020 05 15.
Article em En | MEDLINE | ID: mdl-31860339
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculina / Tuberculose / Broncoscopia / Vacina BCG / Adjuvantes Imunológicos / Imunogenicidade da Vacina Limite: Adult / Female / Humans / Male Idioma: En Revista: Am J Respir Crit Care Med Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: África do Sul
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculina / Tuberculose / Broncoscopia / Vacina BCG / Adjuvantes Imunológicos / Imunogenicidade da Vacina Limite: Adult / Female / Humans / Male Idioma: En Revista: Am J Respir Crit Care Med Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: África do Sul